Associação Brasileira de Cannabis Medicinal | ClinicalTrials HQ

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Oral and Topical Phytocannabinoids for Psoriasis	Chemically-Induced Disorders, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, cannabis dependence, psoriasis, psychiatric disorder, skin disorder, substance-related disorder	Active, not recruiting	Phase 2	2026-09-24		NCT07839455
Full-Spectrum Cannabis Extract for Chronic Pain and Bone Health Biomarkers in Women	Bone Diseases, Metabolic, Chronic Pain, Facial Pain, Neurologic Manifestations, Nutritional and Metabolic Diseases, Orofacial Pain, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, bone disorder, fibromyalgia, metabolic disease, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, neuromuscular disease, osteoporosis, rheumatic disorder	Not yet recruiting	Phase 2	2026-08-26		NCT07783295
Cannabigerol Oil for Adolescents With ADHD (CAN-ADHD)	attention deficit hyperactivity disorder, inattentive type, neurodevelopmental disorder, oppositional defiant disorder, psychiatric disorder	Recruiting	Phase 1 / Phase 2	2026-05-18		NCT07592390
EFFECTS OF A FULL SPECTRUM CANNABIS EXTRACT WITH DIFFERENT DOSES OF CBD AND THC ON THE MODULATION OF FIBROMYALGIA: A PILOT, MULTICENTER, OPEN LABEL CLINICAL TRIAL (FRIDINHA)	Neurobehavioral Manifestations, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, agnosia, fibromyalgia, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, neuromuscular disease, perceptual disorders, rheumatic disorder	Active, not recruiting	Phase 1 / Phase 2	2026-03-27		NCT07498023